Pathology: la/mBC - HR positive - L1 - PIK3CA mutant; la/mBC - HR-positive - 1st line (L1);
| la/mBC - HR positive - L1 - PIK3CA mutant | la/mBC - HR-positive - 1st line (L1) | ||
| IPATunity130, 2022 | BEECH, 2019 | ||
| ipatasertib plus paclitaxel | 1 | T1 | |
| capivasertib plus paclitaxel | 1 | T1 | |
| paclitaxel | 0 | T0 | T0 |